Reports for GLAXOSMITHKLINE INC
Company Name
GLAXOSMITHKLINE INC
Totals |
||
Shortage reports |
322 |
|
| Actual shortage: | 9 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (2%) | |
| Resolved: | 307 (95%) | |
Discontinuation Reports |
56 |
|
| To be discontinued: | 2 (4%) | |
| Discontinued: | 54 (96%) | |
| Reversed: | 0 (0%) | |
Late reports |
4 (1%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLAVULIN 400 | 400MG 57MG | POWDER FOR SUSPENSION | Resolved | 2022-09-09 | 2024-02-14 | 168941 |
| CLAVULIN 250 F ORAL SUS | 250MG 62.5MG | POWDER FOR SUSPENSION | Resolved | 2019-02-08 | 2019-02-13 | 75177 |
| CLAVULIN 250 F ORAL SUS | 62.5MG 250MG | POWDER FOR SUSPENSION | Resolved | 2022-08-10 | 2022-10-27 | 166417 |
| CLAVULIN 250 F ORAL SUS | 62.5MG 250MG | POWDER FOR SUSPENSION | Resolved | 2022-11-18 | 2024-02-14 | 175255 |
| CLAVULIN 200 | 28.5MG 200MG | POWDER FOR SUSPENSION | Resolved | 2022-07-29 | 2022-07-30 | 165692 |
| CLAVULIN 200 | 28.5MG 200MG | POWDER FOR SUSPENSION | Resolved | 2022-10-12 | 2024-02-14 | 171572 |
| CLAVULIN 125 F ORAL SUS | 125MG 31.25MG | POWDER FOR SUSPENSION | Resolved | 2022-10-14 | 2024-02-14 | 171718 |
| CERVARIX | 20MCG 20MCG | SUSPENSION | Resolved | 2018-04-13 | 2018-11-15 | 45668 |
| CEFTIN - TAB 500MG | 500MG | TABLET | Resolved | 2018-01-12 | 2020-07-24 | 35778 |
| CEFTIN - TAB 250MG | 250MG | TABLET | Resolved | 2018-01-12 | 2020-07-24 | 35768 |
| BREO ELLIPTA | 25MCG 100MCG | POWDER | Resolved | 2021-02-26 | 2021-03-05 | 134785 |
| BREO ELLIPTA | 100MCG 25MCG | POWDER | Resolved | 2021-12-17 | 2022-01-05 | 151398 |
| BREO ELLIPTA | 100MCG 25MCG | POWDER | Resolved | 2022-11-11 | 2022-12-01 | 174375 |
| BREO ELLIPTA | 100MCG 25MCG | POWDER | Resolved | 2022-12-16 | 2023-01-04 | 178687 |
| BREO ELLIPTA | 25MCG 200MCG | POWDER | Resolved | 2021-12-17 | 2022-01-05 | 151401 |
| BREO ELLIPTA | 25MCG 200MCG | POWDER | Resolved | 2022-12-16 | 2023-01-04 | 178684 |
| BOOSTRIX-POLIO | 40D 8D 32D 5.0LF 2.5LF 8MCG 8MCG 2.5MCG | SUSPENSION | Resolved | 2017-08-18 | 2017-12-07 | 19888 |
| BOOSTRIX-POLIO | 32D 8D 40D 2.5MCG 8MCG 8MCG 5.0LF 2.5LF | SUSPENSION | Resolved | 2023-06-21 | 2023-10-04 | 196056 |
| BOOSTRIX | 2.5MCG 8MCG 8MCG 20UNIT 2UNIT | SUSPENSION | Resolved | 2023-01-04 | 2023-05-16 | 179831 |
| BEXSERO | 50MCG 50MCG 50MCG 25MCG | SUSPENSION | Resolved | 2018-07-13 | 2018-08-08 | 55706 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CYCLOCORT | 0.1% | CREAM | Discontinued | 2017-11-02 | 2018-01-31 | 27816 |
| COACTIFED | 30MG 2MG 10MG | SYRUP | Discontinued | 2018-06-13 | 2018-06-13 | 52332 |
| CLINDETS | 1% | PAD | Discontinued | 2017-09-19 | 2017-09-19 | 22562 |
| CLAVULIN 875 | 125MG 875MG | TABLET | Discontinued | 2024-01-18 | 2024-01-18 | 216509 |
| CLAVULIN 500 F TAB | 125MG 500MG | TABLET | Discontinued | 2024-02-02 | 2024-02-02 | 218240 |
| CEFTIN - TAB 500MG | 500MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121049 |
| CEFTIN - TAB 250MG | 250MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121046 |
| AVANDIA | 2MG | TABLET | Discontinued | 2020-04-27 | 2020-09-01 | 113311 |
| AVANDIA | 4MG | TABLET | Discontinued | 2020-04-27 | 2020-12-11 | 113314 |
| AVANDIA | 8MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113317 |
| AVANDAMET | 500MG 2MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8077 |
| AVANDAMET | 1000MG 2.00MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8081 |
| AVANDAMET | 1000MG 4.00MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8084 |
| AVANDAMET | 500MG 4MG | TABLET | Discontinued | 2017-04-25 | 2017-05-04 | 8087 |
| AMERGE | 1MG | TABLET | Discontinued | 2021-10-28 | 2022-08-09 | 148427 |
| AMERGE | 2.5MG | TABLET | Discontinued | 2021-10-28 | 2022-12-02 | 148430 |